Vice President, Clinical Development

About Aurabiosciences

aurabiosciences.com

Aura Biosciences is a biotechnology company developing a first‑in‑class technology to treat a wide range of solid tumor types. The company’s initial focus is on cancers where current options force patients to choose between preserving life or function—such as choroidal melanoma—seeking transformational improvements in outcomes. Aura advances targeted therapeutics intended to eliminate tumor cells while sparing healthy tissue and is progressing those candidates through clinical development. They position themselves as an innovator committed to changing standards of care for hard‑to‑treat solid tumors.